Pier 88 Investment Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Sell |
14,730
-7,640
| -34% | -$278K | 0.1% | 85 |
|
|
2025
Q1 | $810K | Buy |
22,370
+8,280
| +59% | +$300K | 0.16% | 64 |
|
|
2024
Q4 | $593K | Sell |
14,090
-8,450
| -37% | -$355K | 0.12% | 68 |
|
|
2024
Q3 | $1.25M | Sell |
22,540
-3,430
| -13% | -$191K | 0.28% | 47 |
|
|
2024
Q2 | $1.07M | Buy |
25,970
+10,700
| +70% | +$440K | 0.24% | 57 |
|
|
2024
Q1 | $713K | Sell |
15,270
-5,320
| -26% | -$248K | 0.18% | 50 |
|
|
2023
Q4 | $985K | Buy |
20,590
+8,910
| +76% | +$426K | 0.25% | 52 |
|
|
2023
Q3 | $416K | Sell |
11,680
-11,620
| -50% | -$414K | 0.1% | 79 |
|
|
2023
Q2 | $1.07M | Buy |
23,300
+1,550
| +7% | +$71.5K | 0.27% | 61 |
|
|
2023
Q1 | $872K | Hold |
21,750
| – | – | 0.21% | 58 |
|
|
2022
Q4 | $1.01M | Sell |
21,750
-1,090
| -5% | -$50.5K | 0.24% | 53 |
|
|
2022
Q3 | $946K | Buy |
22,840
+7,290
| +47% | +$302K | 0.22% | 65 |
|
|
2022
Q2 | $928K | Hold |
15,550
| – | – | 0.22% | 71 |
|
|
2022
Q1 | $1.13M | Hold |
15,550
| – | – | 0.4% | 52 |
|
|
2021
Q4 | $1.31M | Buy |
15,550
+3,460
| +29% | +$291K | 0.28% | 67 |
|
|
2021
Q3 | $1.09M | Buy |
12,090
+5,025
| +71% | +$453K | 0.33% | 66 |
|
|
2021
Q2 | $673K | Buy |
7,065
+1,300
| +23% | +$124K | 0.19% | 90 |
|
|
2021
Q1 | $656K | Buy |
5,765
+2,445
| +74% | +$278K | 0.22% | 81 |
|
|
2020
Q4 | $459K | Sell |
3,320
-8,130
| -71% | -$1.12M | 0.15% | 100 |
|
|
2020
Q3 | $941K | Sell |
11,450
-5,065
| -31% | -$416K | 0.29% | 73 |
|
|
2020
Q2 | $1.29M | Buy |
16,515
+1,850
| +13% | +$145K | 0.37% | 68 |
|
|
2020
Q1 | $652K | Hold |
14,665
| – | – | 0.24% | 66 |
|
|
2019
Q4 | $626K | Buy |
14,665
+1,740
| +13% | +$74.3K | 0.25% | 55 |
|
|
2019
Q3 | $553K | Buy |
12,925
+2,560
| +25% | +$110K | 0.21% | 69 |
|
|
2019
Q2 | $658K | Hold |
10,365
| – | – | 0.28% | 61 |
|
|
2019
Q1 | $719K | Buy |
10,365
+3,050
| +42% | +$212K | 0.33% | 56 |
|
|
2018
Q4 | $318K | Buy |
7,315
+270
| +4% | +$11.7K | 0.16% | 67 |
|
|
2018
Q3 | $538K | Buy |
7,045
+1,245
| +21% | +$95.1K | 0.23% | 60 |
|
|
2018
Q2 | $446K | Buy |
+5,800
| New | +$446K | 0.21% | 64 |
|